Teva Pharmaceutical Industries Aktie
25,70
EUR
-0,10
EUR
-0,39
%
29,96
USD
-0,14
USD
-0,45
%
Werbung
Teva Pharmaceutical Industries Aktie Analyse
| 11.06.19 | Teva Pharmaceutical Industries Underweight | Barclays Capital | |
| 02.02.18 | Teva Pharmaceutical Industries Sell | BTIG Research | |
| 03.11.17 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
| 30.10.17 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
| 18.09.17 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
| 04.08.17 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
| 11.01.07 | Teva Pharmaceutical Industries sell | Jyske Bank | |
| 07.12.06 | Teva Pharmaceutical Industries sell | Jyske Bank | |
|
Werbung
|
|||
| 27.06.06 | Teva Pharmaceutical Industries verkaufen | Nasd@q Inside | |
Werbung
Werbung